Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00318981 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD
A Phase 4 study of Adult ADHD, sponsored by University of Maryland, College Park.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT00318981 is a Phase 4 study of Adult ADHD that has completed, run by University of Maryland, College Park. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00318981, a Phase 4 study of Adult ADHD, has completed, sponsored by University of Maryland, College Park.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study involves a 7 week dose-response trial of Concerta™ methylphenidate for mothers of children with ADHD who have ADHD themselves. The aim of this study is to assess the efficacy of Concerta™ in improving adult ADHD symptoms and impairments (primary outcome), as well as observed and reported parenting (secondary outcome). The researchers hypothesize that Concerta™ will significantly decrease mothers ADHD symptoms and impairment, as well as improve observed and reported parenting
Conditions Studied
Interventions
- DRUG Concerta
Study Locations (1)
Virginia
- Children's National Medical Center Regional Outpatient Center - Fairfax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2004-12 |
| Est. Completion | 2006-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00318981
The ClinicalTrials.gov registry entry for NCT00318981 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, College Park, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Adult ADHD appearing as the primary indexed condition, and to 1 intervention - of which Concerta is the first listed.
NCT00318981 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT00318981 about?
NCT00318981 is a clinical study titled "Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD". This study involves a 7 week dose-response trial of Concerta™ methylphenidate for mothers of children with ADHD who have ADHD themselves. The aim of this study is to assess the efficacy of Concerta™ in improving adult ADHD symptoms and impairments (primary outcome), as well as observed and reported ...
What is the current status of trial NCT00318981?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2004-12. Estimated completion is 2006-12.
What conditions does trial NCT00318981 study?
This clinical trial studies the following conditions: Adult ADHD.
What interventions are being tested in trial NCT00318981?
The interventions under investigation include: Concerta (DRUG).
Who is sponsoring clinical trial NCT00318981?
This trial is sponsored by University of Maryland, College Park, which has 46 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00318981 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.